Mammalian Transient Protein Expression Market Share

North American Market Forecast   

The North America mammalian transient protein expression market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the developing healthcare infrastructure, increasing government funds to support the health industry, the growing presence of prominent players, and rising healthcare expenditure. As of 2019, healthcare expenditures in the region accounted for 16.32% of the overall regional GDP. On the other hand, the surge in the cases of AIDS and STDs is also projected to expand the market size in the region during the forecast period. The prevalence of these diseases is observed to be higher in bisexuals, men who have sex with men (MSM), and others. For instance, the percentage of MSM and men who have sex with both men and women (MSMW) was projected to be around 45% in the regional population. Additionally, the number of people in the USA suffering from HIV reached approximately 35,000 in 2022. The market is further projected to grow on the back of escalating cases of various types of cancers in the region which is increasing the requirement for effective treatment along with efficient cancer services.  Data released by the Centers for Disease Control and Prevention in 2029 showed that 599,589 people lost their lives while 1,752,735 new cases of cancer were diagnosed.